Curie: Healthcare in Focus

Curie: Healthcare in Focus

di Curie

Medicina Commenti di notizie

Stagione 1

Science Under Siege: How NIH Cuts Could Cripple Medical Innovation

Love what you hear? Download the Curie app from the App Store for expert-driven healthcare content tailored to your interests. The National Institutes of Health (NIH) has long been the backbone of U.S. biomedical research—but a new wave of budget cuts could change that. With $4 billion in funding on the line, clinical trials are at risk, research programs are in limbo, and top scientists may start looking elsewhere. In this episode of Curie, Matt investigates how these cuts are already sending shockwaves through the scientific community and what this means for the future of medical innovation.

Why Some Doctors Never Hang Up the White Coat

Love what you hear? Download the Curie app from the App Store today. Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals. Retirement isn’t what it used to be—especially for physicians. With financial pressures, a deep sense of professional identity, and a worsening physician shortage, more doctors are choosing to keep practicing well beyond traditional retirement age. In this episode of Curie, Matt investigates why some physicians never step away, the rise of encore careers, and what this means for the future of medicine.

ASCO Ovarian Cancer Guidelines, Mammo-50 Breast Cancer Surveillance, and NRG1 Fusion Therapy Advances

Love what you hear? Download the Curie app from the App Store today. Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals. In this episode of Curie, Matt breaks down three major updates in oncology. ASCO has released updated guidelines for advanced ovarian cancer, emphasizing primary cytoreductive surgery over neoadjuvant chemotherapy when feasible. The Mammo-50 trial challenges the standard of annual mammographic surveillance for breast cancer survivors over 50, showing that less frequent screening is non-inferior. Finally, the eNRGy trial confirms the efficacy of zenocutuzumab in treating NRG1 fusion-positive cancers, a rare but actionable oncogenic driver in NSCLC and pancreatic cancer. Tune in for expert insights into how these findings are shaping cancer care.

COVID Conspiracies Are Back—And They're Targeting Healthcare

Love what you hear? Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals. Download the Curie app from the App Store today. COVID-19 conspiracy theories aren’t just lingering—they’re growing, evolving, and shaping how patients interact with medicine. In this episode of Curie, Matt unpacks the resurgence of COVID misinformation, why it's thriving in 2025, and how healthcare professionals can push back against the false narratives affecting public health.

Bird Flu (H5N1) in 2025

You can download the Curie app from the App Store here for more expert-driven healthcare related content. H5N1 has spread to dairy cattle—and human infections are following. What does this mean for medicine and public health? In this episode of Curie, Matt unpacks the rise of bird flu in 2025, the latest case numbers, and whether this new variant is a pandemic threat.

Pharma Ads in the Super Bowl: The High-Stakes Play for Patient Attention

Pharma is making its way onto the biggest advertising stage of the year—the Super Bowl. But should these ads be part of the spectacle? In this episode of Curie, Matt investigates why more pharmaceutical brands are investing in high-profile TV spots, the ethics of direct-to-consumer drug marketing, and what this means for healthcare professionals navigating patient conversations.

ASCO GI 2025 Highlights: Transforming Gastrointestinal Cancer Care

ASCO GI 2025 delivered big wins in gastrointestinal oncology. We highlight key findings, including nivolumab-plus-ipilimumab in MSI-H mCRC, encorafenib-based regimens for BRAF-mutant CRC, and innovative strategies in CAR-T therapies. Catch up on the most impactful data shaping the future of cancer care. Like what you hear? Download Curie from App Store for more in-depth insights in onlcology and general medicine.

Disrupting Healthcare: The Impact of Trump’s Policies

Trump’s second term is already bringing massive changes to U.S. healthcare—Medicaid funding freezes, ACA rollbacks, and an exit from the WHO. What does it mean for physicians, hospitals, and public health? Matt breaks down the sweeping policies reshaping American medicine. If you find this episode insightful, download the Curie app from the App Store for more expert-driven healthcare content

Global Health Without the U.S.?

What happens when the U.S. steps away from global health leadership? In this episode of Curie, Matt explores the potential consequences of leaving the WHO, from vaccine development disruptions to the growing influence of other nations in global health policy. If you enjoy this episode, download the Curie app from the App Store for more in-depth healthcare insights.

The EHR Dilemma: How Digital Tools Are Fueling Physician Burnout

Electronic health records promised to transform healthcare, but are they doing more harm than good? In this episode of Curie, we dive into how EHRs contribute to physician burnout, explore the hidden costs to patient care, and discuss solutions to reclaim their promise. If you find this episode valuable, download the Curie app from the App Store for more curated healthcare content.

6 di 8